Our Hub-EGFR.Sig recognition by multiple ML algorithms was based on the importance of genes for immunotherapy, and deep analysis revealed that most of the genes in Hub-EGFR.Sig could independently affect the prognosis of BLCA. The gene discussed is EGFR; the disease is bladder transitional cell carcinoma.